JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has informed the stock exchange that the trading window for dealing in its securities will be closed from June 30, 2025 until 48 hours after the Board declares the unaudited financial results for the quarter ending June 30, 2025. This is a standard regulatory compliance under SEBI's Prohibition of Insider Trading Regulations, 2015. The closure restricts directors, key managerial personnel, and other designated persons from trading in the company's shares during this period. The move essentially signals that the company's Q1 FY26 earnings announcement is imminent.
No direct impact on share price expected as this is routine compliance. However, it indicates that Q1 FY26 results will be announced soon, which could be a catalyst depending on the numbers delivered.